Healthcare Realty Trust (NYSE:HR) Issues FY 2024 Earnings Guidance

Healthcare Realty Trust (NYSE:HRGet Free Report) updated its FY 2024 earnings guidance on Saturday. The company provided EPS guidance of 1.530-1.580 for the period, compared to the consensus EPS estimate of 1.550. The company issued revenue guidance of -.

Healthcare Realty Trust Trading Up 0.2 %

Shares of HR opened at $17.94 on Friday. Healthcare Realty Trust has a 12-month low of $12.77 and a 12-month high of $18.90. The company has a market cap of $6.79 billion, a PE ratio of -13.49 and a beta of 0.91. The stock has a 50-day moving average price of $17.81 and a 200-day moving average price of $16.06.

Healthcare Realty Trust (NYSE:HRGet Free Report) last released its quarterly earnings results on Friday, August 2nd. The real estate investment trust reported ($0.39) EPS for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.77). The company had revenue of $316.30 million during the quarter, compared to analysts’ expectations of $317.90 million. Healthcare Realty Trust had a negative return on equity of 8.50% and a negative net margin of 42.79%. Healthcare Realty Trust’s quarterly revenue was down 6.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.39 EPS. As a group, analysts predict that Healthcare Realty Trust will post 1.56 earnings per share for the current year.

Healthcare Realty Trust Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 28th. Investors of record on Monday, August 12th were paid a $0.31 dividend. The ex-dividend date of this dividend was Monday, August 12th. This represents a $1.24 dividend on an annualized basis and a yield of 6.91%. Healthcare Realty Trust’s dividend payout ratio is presently -93.23%.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the company. Wedbush upped their price objective on Healthcare Realty Trust from $15.00 to $18.00 and gave the stock a neutral rating in a report on Monday, August 5th. Scotiabank boosted their target price on Healthcare Realty Trust from $17.00 to $18.00 and gave the stock a sector perform rating in a research report on Wednesday, August 7th. Finally, Wells Fargo & Company cut shares of Healthcare Realty Trust from an equal weight rating to an underweight rating and reduced their price target for the company from $17.00 to $16.00 in a research report on Tuesday, July 30th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of Hold and an average target price of $17.00.

Check Out Our Latest Report on Healthcare Realty Trust

Insider Buying and Selling

In related news, Director John Knox Singleton acquired 6,500 shares of the stock in a transaction on Thursday, September 5th. The stock was purchased at an average price of $18.24 per share, for a total transaction of $118,560.00. Following the completion of the transaction, the director now owns 57,082 shares of the company’s stock, valued at approximately $1,041,175.68. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. In other Healthcare Realty Trust news, Director Thomas N. Bohjalian bought 9,000 shares of the business’s stock in a transaction that occurred on Monday, August 12th. The shares were bought at an average cost of $17.39 per share, with a total value of $156,510.00. Following the completion of the purchase, the director now directly owns 22,252 shares of the company’s stock, valued at $386,962.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director John Knox Singleton purchased 6,500 shares of the stock in a transaction on Thursday, September 5th. The shares were acquired at an average cost of $18.24 per share, with a total value of $118,560.00. Following the transaction, the director now directly owns 57,082 shares in the company, valued at $1,041,175.68. The disclosure for this purchase can be found here. Insiders have purchased a total of 15,728 shares of company stock worth $279,069 in the last ninety days. 0.56% of the stock is owned by insiders.

Healthcare Realty Trust Company Profile

(Get Free Report)

Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets.

Featured Articles

Earnings History and Estimates for Healthcare Realty Trust (NYSE:HR)

Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.